Clinical Pharmacogenomic MT‐RNR1 Screening for Aminoglycoside‐Induced Ototoxicity and the Post‐Test Counseling Conundrum
Clinical Pharmacology & Therapeutics · 2023
DOI: 10.1002/cpt.2910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Robert Rigobello und 7 weiteren Autor:innen. Beteiligte Einrichtung: GeneDx, Gaithersburg, Maryland, USA. Hauptthemen laut MEDLINE: Aminoglycosides, Genes, rRNA, Ototoxicity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Aminoglycoside antibiotic exposure can result in ototoxicity and irreversible hearing loss among individuals that harbor the m.1555A>G variant in the mitochondrial 12S rRNA gene, MT‐RNR1 . Importantly, pre‐emptive m.1555A>G screening has been shown to reduce the prevalence of pediatric aminoglycoside‐induced ototoxicity; however, professional guidelines to support and guide post‐test pharmacogenomic counseling in this context are not currently available. This Perspective highlights key issues with delivering MT‐RNR1 results, including longitudinal familial care considerations and communicating m.1555A>G heteroplasmy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GeneDx, Gaithersburg, Maryland, USA.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Pathology, Stanford University, Stanford, California, USA.
- Clinical Genomics Laboratory, Stanford Medicine, Palo Alta, California, USA.
ORCID-Profile: Robert Rigobello, Jay Shaw, Daniel Ilg, Rebekah Zimmerman, Lisa Edelmann, Stuart A Scott
Zitieren
APA
Rigobello, R., Shaw, J., Ilg, D., Zimmerman, R., Edelmann, L., Kornreich, R., Scott, S. A., & Cody, N. (2023). Clinical Pharmacogenomic MT‐RNR1 Screening for Aminoglycoside‐Induced Ototoxicity and the Post‐Test Counseling Conundrum. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2910
Vancouver
Rigobello R, Shaw J, Ilg D, Zimmerman R, Edelmann L, Kornreich R, et al. Clinical Pharmacogenomic MT‐RNR1 Screening for Aminoglycoside‐Induced Ototoxicity and the Post‐Test Counseling Conundrum. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.2910
BibTeX
@article{Rigobello2023,
author = {Rigobello, Robert and Shaw, Jay and Ilg, Daniel and Zimmerman, Rebekah and Edelmann, Lisa and Kornreich, Ruth and Scott, Stuart A and Cody, Neal},
title = {Clinical Pharmacogenomic MT‐RNR1 Screening for Aminoglycoside‐Induced Ototoxicity and the Post‐Test Counseling Conundrum},
journal = {Clinical Pharmacology & Therapeutics},
year = {2023},
doi = {10.1002/cpt.2910}
}
EUVIMED